Asker Healthcare Group AB
Asker Healthcare Group AB provides medical supplies, devices, and equipment, and related solutions that support patient care. It offers protective products, infusion products, and dressings; measuring instruments for diabetes and blood pressure; and endoscopy equipment, incubators, and ventilators, as well as pharmaceuticals. The company also provides, supplies, and distributes fittings and equip… Read more
Market Cap & Net Worth: Asker Healthcare Group AB (I88)
Asker Healthcare Group AB (F:I88) has a market capitalization of $2.30 Billion (€2.24 Billion) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #6181 globally and #651 in its home market, demonstrating a -4.26% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Asker Healthcare Group AB's stock price €5.84 by its total outstanding shares 383036497 (383.04 Million).
Asker Healthcare Group AB Market Cap History: 2026 to 2026
Asker Healthcare Group AB's market capitalization history from 2026 to 2026. Data shows growth from $2.30 Billion to $2.30 Billion (0.00% CAGR).
Asker Healthcare Group AB Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Asker Healthcare Group AB's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of I88 by Market Capitalization
Companies near Asker Healthcare Group AB in the global market cap rankings as of March 18, 2026.
Key companies related to Asker Healthcare Group AB by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #164 globally with a market cap of $115.38 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #340 globally with a market cap of $64.39 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #428 globally with a market cap of $51.10 Billion USD.
- Sigma Healthcare Limited (OTCGREY:SIGGF): Ranked #1455 globally with a market cap of $12.16 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #164 | McKesson Corporation | NYSE:MCK | $115.38 Billion | $943.25 |
| #340 | Cencora Inc. | NYSE:COR | $64.39 Billion | $345.88 |
| #428 | Cardinal Health Inc | NYSE:CAH | $51.10 Billion | $217.59 |
| #1455 | Sigma Healthcare Limited | OTCGREY:SIGGF | $12.16 Billion | $1.88 |
Asker Healthcare Group AB Historical Marketcap From 2026 to 2026
Between 2026 and today, Asker Healthcare Group AB's market cap moved from $2.30 Billion to $ 2.30 Billion, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €2.30 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Asker Healthcare Group AB was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.30 Billion USD |
| MoneyControl | $2.30 Billion USD |
| MarketWatch | $2.30 Billion USD |
| marketcap.company | $2.30 Billion USD |
| Reuters | $2.30 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.